In the BioHarmony Drug Report Database
Viberzi (eluxadoline) is a small molecule pharmaceutical. Eluxadoline was first approved as Viberzi on 2015-05-27. It is used to treat irritable bowel syndrome in the USA. It is known to target mu-type opioid receptor and delta-type opioid receptor. Viberzi’s patents are valid until 2033-03-14 (FDA).
Image (chem structure or protein)